Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone.
Daniela
Manno
;
Philip
Ayieko
;
David
Ishola
;
Muhammed O
Afolabi
;
Baimba
Rogers
;
Frank
Baiden
;
Alimamy
Serry-Bangura
;
Osman M
Bah
;
Brian
Köhn
;
Ibrahim
Swaray
;
+14 more...
Kwabena
Owusu-Kyei
;
Godfrey T
Otieno
;
Dickens
Kowuor
;
Daniel
Tindanbil
;
Elizabeth
Smout
;
Cynthia
Robinson
;
Babajide
Keshinro
;
Julie
Foster
;
Katherine
Gallagher
;
Brett
Lowe
;
Macaya
Douoguih
;
Bailah
Leigh
;
Brian
Greenwood
;
Deborah
Watson-Jones
;
(2022)
Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone.
Emerging Infectious Diseases, 28 (3).
pp. 734-738.
ISSN 1080-6040
DOI: 10.3201/eid2803.211496
;
Philip
Ayieko
;
David
Ishola
;
Muhammed O
Afolabi
;
Baimba
Rogers
;
Frank
Baiden
;
Alimamy
Serry-Bangura
;
Osman M
Bah
;
Brian
Köhn
;
Ibrahim
Swaray
;
+14 more...
Kwabena
Owusu-Kyei
;
Godfrey T
Otieno
;
Dickens
Kowuor
;
Daniel
Tindanbil
;
Elizabeth
Smout
;
Cynthia
Robinson
;
Babajide
Keshinro
;
Julie
Foster
;
Katherine
Gallagher
;
Brett
Lowe
;
Macaya
Douoguih
;
Bailah
Leigh
;
Brian
Greenwood
;
Deborah
Watson-Jones
;
(2022)
Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone.
Emerging Infectious Diseases, 28 (3).
pp. 734-738.
ISSN 1080-6040
DOI: 10.3201/eid2803.211496
We explored the association of Ebola virus antibody seropositivity and concentration with potential risk factors for infection. Among 1,282 adults and children from a community affected by the 2014-2016 Ebola outbreak in Sierra Leone, 8% were seropositive for virus antibodies but never experienced disease symptoms. Antibody concentration increased with age.
-
picture_as_pdf - Manno_etal_2022_Ebola-virus-glycoprotein-igg-seroprevalence.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution 4.0
Downloads